Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/32990
Title: Reversibility of Diffusion-Weighted Imaging Lesions in Patients With Ischemic Stroke in the WAKE-UP Trial.
Austin Authors: Scheldeman, Lauranne;Wouters, Anke;Bertels, Jeroen;Dupont, Patrick;Cheng, Bastian;Ebinger, Martin;Endres, Matthias;Fiebach, Jochen B;Gerloff, Christian;Muir, Keith W;Nighoghossian, Norbert;Pedraza, Salvador;Simonsen, Claus Z;Thijs, Vincent N ;Thomalla, Götz;Lemmens, Robin
Affiliation: Department of Neurology, University Hospitals Leuven, Belgium
Department of Neurosciences, Experimental Neurology KU Leuven, University of Leuven
Processing Speech and Images, Department of Electrial Engineering, University of Leuven, Belgium
Department of Neurosciences, Laboratory for Cognitive Neurology KU Leuven, University of Leuven, Belgium
Klinik und Poliklinik für Neurologie, Kopf- und Neurozentrum, University Medical Center Hamburg-Eppendorf, Germany
Center for Stroke Research Berlin Charit. - Universit.tsmedizin Berlin, Germany
Klinik und Hochschulambulanz für Neurologie, Charit. - Universit.tsmedizin Berlin, Germany
Neurology
School of Psychology & Neuroscience, University of Glasgow, United Kingdom
Department of Stroke Medicine, Universit. Claude Bernard Lyon 1, CREATIS CNRS UMR 5220-INSERM U1206, INSA- Lyon, Hospices Civils de Lyon, France
Department of Radiology, Institut de Diagnostic per la Image Hospital Dr Josep Trueta, Institut d'Investigaci. Biomedica de Girona Parc Hospitalari Marti i Julia de Salt - Edifici M2, Girona, Spain
Department of Neurology, Aarhus University Hospital, Denmark
The Florey Institute of Neuroscience and Mental Health
ExcellenceCluster NeuroCure
Center for Brain and Disease Research, Laboratory of Neurobiology, VIB, Leuven, Belgium
German Center for Neurodegenerative Diseases, partner site Berlin
Department of Neurology, Amsterdam University Medical Centers, the Netherlands
Leuven Brain Institute, Belgium
Klinik für Neurologie, Medical Park Berlin Humboldtmühle, Germany
German Center for Cardiovascular Research, partner site Berlin
Issue Date: Jun-2023
Date: 2023
Publication information: Stroke 2023
Abstract: Reversibility of the diffusion-weighted imaging (DWI) lesion means that not all of the DWI lesion represents permanently injured tissue. We investigated DWI reversibility and the association with thrombolysis, reperfusion and functional outcome in patients from the WAKE-UP trial (Efficacy and Safety of Magnetic Resonance Imaging-Based Thrombolysis in Wake-Up Stroke). In this retrospective analysis of WAKE-UP, a randomized controlled trial (RCT) between September 2012 and June 2017 in Belgium, Denmark, France, Germany, Spain and United Kingdom, a convolutional neural network segmented the DWI lesions (b=1000 s/mm2) at baseline and follow-up (24 hours). We calculated absolute and relative DWI reversibility in 2 ways: first, a volumetric (baseline volume-24-hour volume >0) and second, a voxel-based (part of baseline lesion not overlapping with 24-hour lesion) approach. We additionally defined relative voxel-based DWI-reversibility >50% to account for coregistration inaccuracies. We calculated the odds ratio for reversibility according to treatment arm. We analyzed the association of reversibility with excellent functional outcome (modified Rankin Scale score of 0-1), in a multivariable model. In 363 patients, the median DWI volume was 3 (1-10) mL at baseline and 6 (2-20) mL at follow-up. Volumetric DWI reversibility was present in 19% (69/363) with a median absolute reversible volume of 1 mL (0-2) or 28% (14-50) relatively. Voxel-based DWI reversibility was present in 358/363 (99%) with a median absolute volume of 1 mL (0-2), or 22% (9-38) relatively. In 18% of the patients (67/363), relative voxel-based DWI reversibility >50% was present. Volumetric DWI reversibility and relative voxel-based DWI reversibility >50% was more frequent in patients treated with alteplase versus placebo (OR, 1.86 [95% CI, 1.09-3.17] and OR, 2.03 [95% CI, 1.18-3.50], respectively). Relative voxel-based DWI reversibility >50% was associated with excellent functional outcome (OR, 2.30 [95% CI, 1.17-4.51]). Small absolute volumes of DWI reversibility were present in a large proportion of randomized patients in the WAKE-UP trial. Reversibility was more often present after thrombolysis.
URI: https://ahro.austin.org.au/austinjspui/handle/1/32990
DOI: 10.1161/STROKEAHA.122.041505
ORCID: 0000-0002-5263-3550
0000-0001-5229-2699
0000-0001-7206-2671
0000-0003-1980-2540
0000-0003-2434-1822
0000-0002-5073-4665
0000-0001-6520-3720
0000-0002-7936-6958
0000-0002-6484-8882
0000-0003-0594-4409
0000-0003-2517-4413
0000-0003-1363-0266
0000-0002-6614-8417
0000-0002-4785-1449
0000-0002-4948-5956
Journal: Stroke
Start page: 1560
End page: 1568
PubMed URL: 37158080
ISSN: 1524-4628
Type: Journal Article
Subjects: arm
diagnosis
ischemic stroke
odds ratio
reperfusion
Stroke/diagnostic imaging
Stroke/drug therapy
Stroke/pathology
Diffusion Magnetic Resonance Imaging/methods
Tissue Plasminogen Activator/therapeutic use
Ischemic Stroke/drug therapy
Appears in Collections:Journal articles

Show full item record

Page view(s)

34
checked on Nov 7, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.